spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Molinete, M.
Right arrow Articles by Halban, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Molinete, M.
Right arrow Articles by Halban, P. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Role of clathrin in the regulated secretory pathway of pancreatic ß-cells

Miguel Molinete1, Stéphane Dupuis1, Frances M. Brodsky2 and Philippe A. Halban1,*

1 Louis-Jeantet Research Laboratories, University Medical Centre, 1 rue Michel Servet, 1211 Geneva 4, Switzerland
2 G. W. Hooper Foundation, Department of Microbiology and Immunology, and Departments of Pharmaceutical Sciences and Pharmaceutical Chemistry, University of California, San Francisco, CA 94143, USA
* Author for correspondence (e-mail: philippe.halban{at}medecine.unige.ch )



View larger version (41K):

[in a new window]
 
Fig. 1. Effect of Hub expression on immunolocalization by confocal microscopy of clathrin light chain and proinsulin. Rat islet cells were infected with Adeno-Hub/EGFP (a recombinant adenovirus expressing both the Hub peptide and EGFP such that the latter is a marker for Hub expression) or with Adeno-EGFP (only expressing EGFP) as indicated. The left-hand images show direct EGFP fluorescence. Right-hand images show staining for (A) clathrin light chain; (B) proinsulin. Control cells infected with Adeno-EGFP show a strong perinuclear and punctate staining for clathrin light chain regardless of the level of EGFP expression (A: lower). Expression of Hub leads to the disappearance of the perinuclear and punctate staining pattern for clathrin light chain in those cells with the highest level of expression of EGFP (and thus Hub — see representative cell marked by arrow in A: upper), whereas cells in the same cluster but expressing low or nondetectable levels of EGFP (and thus Hub) present normal clathrin light chain staining (see representative cell marked by arrowhead in A: upper). Proinsulin immunostaining (B) was unaffected by expression of Hub, with all cells presenting the same staining pattern regardless of the level of EGFP expression. Bar, 10 µm.

 


View larger version (17K):

[in a new window]
 
Fig. 2. Reverse phase HPLC analysis of radioactive products in islet cells. Cells were pulse-labelled and then chased for 150 minutes under basal conditions before stimulation with a cocktail of secretagogues for 60 minutes. The representative profile is for radioactive products released during this 60 minute period with elution times for the two nonallelic rat I and II proinsulins (PI) and their conversion products as indicated by the arrows. *Elution times of the conversion intermediates des-31,32-split proinsulin I and II, and des-64,65-split proinsulin I and II (reading from left to right); tCP, truncated (des-(27-31)-) C-peptide.

 


View larger version (15K):

[in a new window]
 
Fig. 3. Efficiency of sorting of proinsulin to the regulated secretory pathway is unaffected by Hub. Cells were infected with recombinant adenovirus expressing only EGFP (control) or EGFP and Hub (Hub). Those cells expressing the highest levels of EGFP (and thus Hub) were sorted by FACS and pulse-labelled for 10 minutes with [3H]leucine before a 150 minute chase under basal conditions. Labelled proinsulin and insulin secreted during this time and that remaining within in the cells at the end of the incubation was quantified by HPLC (see Fig. 2). The percentage of labelled proinsulin directed to the regulated secretory pathway was calculated as 100—x, where x is the percentage of labelled proinsulin released without conversion during the 150 minute chase (and attributed to constitutive secretion) and is presented as mean±s.e.m., n=4. Note the interrupted scale. Sorting efficiency was >99% regardless of whether Hub was expressed in the cells or not.

 


View larger version (18K):

[in a new window]
 
Fig. 4. Expression of Hub does not affect the conversion of proinsulin to insulin. Cells were infected with adenovirus, sorted and labelled as described in the legend to Fig. 3. After the 150 minute basal chase, cells were incubated for a further 60 minutes in the presence of secretagogues. The basal and stimulated chase media and extracts of cells at the end of the two chase periods were analysed by HPLC as described in Fig. 2. Proinsulin conversion (mean±s.e.m., n=4) is presented as labelled insulin/labelled proinsulin + intermediates + insulin x 100 (corrected for the difference in the number of leucines in each).

 


View larger version (18K):

[in a new window]
 
Fig. 5. Expression of Hub does not affect the release of proinsulin/insulin. Cells were infected with adenovirus, sorted and labelled as described in the legend to Fig. 3. Samples of medium, following a 150 minute incubation under basal conditions and a subsequent 60 minute period of stimulation, as well as cell extracts (after the stimulation) were analysed by HPLC (see Fig. 2). Labelled proinsulin and insulin (corrected for the difference in the number of leucines in each) is presented as a percentage of that found in all samples (basal + stimulated medium + extracts). Data are mean±s.e.m., n=4.

 


View larger version (16K):

[in a new window]
 
Fig. 6. Expression of Hub increases truncation of C-peptide. Cells were infected with adenovirus, sorted and labelled as described in the legend to Fig. 3. Radioactive truncated (des-(27-31)-) and intact C-peptide were quantified by HPLC (see Fig. 2). Truncated C-peptide is expressed as a percentage of total detectable labelled C-peptide (intact + truncated). Data are mean±s.e.m., n=4. *P<0.01 for Hub vs control for products released during the 150 minute basal chase.

 


View larger version (14K):

[in a new window]
 
Fig. 7. Expression of Hub increases C-peptide degradation (relative to insulin) at later times of chase and in the steady state. Cells were infected with adenovirus and sorted as described in the legend to Fig. 3. (A) Pulse-chase. The sorted cells were labelled (10 minutes [3H]leucine) and chased (150 minutes basal followed by 60 minutes stimulated). The two chase media were analyzed by HPLC. The data (mean±s.e.m., n=4) are for the ratio of labelled insulin to total (intact plus truncated) labelled C-peptide (corrected for the difference in the number of leucines in each). *P<0.02 for Hub vs control for products released during the 60 minute chase with secretagogues (`stimulated'). (B) Steady-state. The sorted cells were incubated for 150 minutes under basal conditions and then for a further 60 minutes with secretagogues. In order to estimate the ratio of (unlabelled) insulin:C-peptide, the 60 minute stimulated medium was analysed by HPLC and the peaks monitored by an online spectrophotometer at 213 nm. Peak areas for C-peptide I and insulin I were measured. The insulin:C-peptide ratio for cells expressing Hub was normalized to that for control cells (for which the measured value was 2.45±0.27). Data are presented as mean±s.e.m., n=5 from four independent experiments. *P<0.005.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




© The Company of Biologists Ltd 2001